Vitafoods Asia 2025 Preview: EffePharm to Present UTHEVER®, UthPeak®, and LipoAvail™ Advances
2025-09-08 | Irene, EffePharm
Summary
EffePharm, a global NAD+ manufacturer and liposomal pioneer, will showcase UTHEVER® NMN, UthPeak® NMNH, and LipoAvail® technology at Vitafoods Asia 2025 in Bangkok, Sept 17–19.
Bulk NMN Manufacturer and Liposomal Pioneer Unveils Clinically Backed Anti-Aging Solutions and Next-Gen Delivery Tech in Bangkok
BANGKOK, THAILAND, September 10, 2025. EffePharm, a global leader in science-driven bioactive ingredients, is set to make waves at Vitafoods Asia 2025, the region’s premier event for health and nutrition innovation. As a trusted NAD+ manufacturer, bulk NMN supplier, and pioneer in liposomal delivery systems, the company will showcase groundbreaking products, including UTHEVER® NMN,UthPeak® NMNH (reduced NMN), and its proprietary LipoAvail® liposomal technology with higher absorption, at Booth L05 from September 17–19, 2025, at Bangkok’s Queen Sirikit National Convention Center.
NAD+ Anti-Aging Solutions: Clinically Proven Pathways to Healthy Aging
At the heart of EffePharm’s showcase is its portfolio of NAD+ (nicotinamide adenine dinucleotide) enhancement solutions, designed to support cellular vitality and healthy aging through rigorous scientific validation.
UTHEVER® NMN: The Gold Standard in NAD+ Precursors
UTHEVER® NMN (nicotinamide mononucleotide) stands as the world’s most clinically advanced NMN brand, having completed large-scale human trials and leading global regulatory compliance. As the first NMN to pass the EU Novel Food public consultation phase, it is now under final review by the European Food Safety Authority (EFSA), with full approval expected in 2025. To further solidify its efficacy, EffePharm has launched Phase II human trials, reinforcing its commitment to evidence-based innovation.
UthPeak® NMNH: Redefining NAD+ Elevation
UthPeak® NMNH (reduced NMN) marks a leap forward in NAD+ supplementation. As the first globally validated NMNH brand via long-term human trials, it delivers unprecedented results: a 3x higher NAD+ boost after 90 days of use (outperforming traditional NAD in clinical tests). Trials also confirmed remarkable health benefits, including a 5-year biological age reversal, a 35% increase in energy levels, and a 31% improvement in mood, all backed by Self-GRAS certification for safety.
LipoAvail® NAD+: Overcoming Absorption Barriers
EffePharm’s proprietary LipoAvail® liposomal technology transforms NAD+ delivery by solving the challenge of poor absorption in large molecules. Clinical data show LipoAvail® NAD+ increases NAD+ levels by 150%, setting a new standard for bioavailability in anti-aging supplements.
LipoAvail® Liposomal Technology: Precision Delivery for Unmatched Absorption
Beyond NAD+, EffePharm’s LipoAvail® liposomal technology is revolutionizing how nutrients are absorbed, addressing a critical pain point in traditional supplements: low bioavailability. This cutting-edge system uses tiny lipid vesicles to protect and deliver ingredients directly to cells, ensuring maximum uptake.
Key Applications of LipoAvail®:
LipoAvail® Glutathione: Demonstrates a 13x increase in bioavailability, enabling significantly higher absorption to strengthen cellular antioxidant defenses and combat oxidative stress.
LipoAvail® Vitamin C: Shows a 7.86x greater relative bioavailability compared to standard forms, overcoming absorption barriers to support immunity and collagen synthesis more effectively.
LipoAvail® Curcumin: Achieves an extraordinary 107.5x higher relative bioavailability, unlocking curcumin’s full anti-inflammatory and antioxidant potential for targeted wellness support.
Fibulous™: Science-Backed Weight Management
EffePharm’s innovation extends beyond anti-aging with Fibulous™, a multi-mechanistic weight management system. Combining white kidney bean extract (to block carb absorption), a composite fiber blend (for gut health and satiety), and AKK bacteria (to balance gut microbiota), Fibulous™ offers a holistic approach to metabolic wellness.
Meet EffePharm at Vitafoods Asia 2025
Industry professionals, partners, and innovators are invited to visit Booth L05 to explore EffePharm’s latest breakthroughs. Attendees can expect live demos of UTHEVER® NMN, UthPeak® NMNH, and LipoAvail® liposomal technology, plus expert insights into science-backed nutraceutical development.
Date: September 17–19, 2025
Venue: Queen Sirikit National Convention Center, Bangkok, Thailand
Booth: L05
About EffePharm
Founded in 2017, EffePharm is a biotech company that provides science-backed bioactive ingredients to address unmet nutritional needs. Its mission is to empower individuals to take control of their health with innovative bioscience applications. With more than 3,000 business partners worldwide, EffePharm delivers efficacy-verified products that benefit millions of consumers on their wellness journeys.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.